Immunyx Pharma
Immunyx has developed targeted neutrophil nanoparticles (TENNs) to solve the major hurdles in treating neutrophils in disease, with a focus on therapies for colitis and cancer.
Immunyx has developed targeted neutrophil nanoparticles (TENNs) to solve the major hurdles in treating neutrophils in disease, with a focus on therapies for colitis and cancer.